THE US AUTHORITIES APPROVE A MEDICATION FROM SANOFI FOR THE TREATMENT OF DIABETES IN CHILDREN OVER ONE YEAR OLD.
https://cdn1-m.alittihad.ae/store/archive/image/2023/11/13/d98a0198-e86a-44db-9690-4c6215cb2b4d.jpg
✍️ The US has expanded the licensing of Tzield, a medication for type 1 diabetes, to children as young as one year old, according to French pharmaceutical company Sanofi.
👉 US FDA approves Tzield for children as young as one year old 👉 Tzield is used to slow the progression of type 1 diabetes 👉 Medication is administered through an intravenous route 👉 Tzield is a chronic disease treatment, not a cure 👉 Sanofi acquired Proven Bio in 2023 for $2.9 billion
-- #KimberSimons #UnitedStates #Europe #Orlando #health
Loading quoted post…
